Filtered By:
Specialty: Internal Medicine
Source: Annals of Internal Medicine
This page shows you your search results in order of relevance. This is page number 12.
Order by Relevance | Date
Total 404 results found since Jan 2013.
In ischemic stroke, IV alteplase within 3 h of onset improves functional outcome vs. control
Ann Intern Med. 2022 Sep 6. doi: 10.7326/J22-0069. Online ahead of print.ABSTRACTMun KT, Bonomo JB, Liebeskind DS, et al. Fragility index meta-analysis of randomized controlled trials shows highly robust evidential strength for benefit of < 3 hour intravenous alteplase. Stroke. 2022;53:2069-74. 35543129.PMID:36063553 | DOI:10.7326/J22-0069
Source: Annals of Internal Medicine - September 5, 2022 Category: Internal Medicine Authors: Barnet Eskin Source Type: research
In acute ischemic stroke, thrombectomy was not noninferior to alteplase + thrombectomy for 90-d functional independence
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0088. Online ahead of print.ABSTRACTFischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104-15. 35810756.PMID:36315954 | DOI:10.7326/J22-0088
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Anthony A Donato Vaibhav Goswami Source Type: research
In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0090. Online ahead of print.ABSTRACTMenon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400:161-9. 35779553.PMID:36315948 | DOI:10.7326/J22-0090
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Emma Ferguson Eddy Lang Source Type: research
In acute ischemic stroke, thrombectomy was not noninferior to alteplase + thrombectomy for 90-d functional independence
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0088. Online ahead of print.ABSTRACTFischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104-15. 35810756.PMID:36315954 | DOI:10.7326/J22-0088
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Anthony A Donato Vaibhav Goswami Source Type: research
In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0090. Online ahead of print.ABSTRACTMenon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400:161-9. 35779553.PMID:36315948 | DOI:10.7326/J22-0090
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Emma Ferguson Eddy Lang Source Type: research
In acute ischemic stroke, thrombectomy was not noninferior to alteplase + thrombectomy for 90-d functional independence
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0088. Online ahead of print.ABSTRACTFischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104-15. 35810756.PMID:36315954 | DOI:10.7326/J22-0088
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Anthony A Donato Vaibhav Goswami Source Type: research
In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0090. Online ahead of print.ABSTRACTMenon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400:161-9. 35779553.PMID:36315948 | DOI:10.7326/J22-0090
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Emma Ferguson Eddy Lang Source Type: research
In acute ischemic stroke, thrombectomy was not noninferior to alteplase + thrombectomy for 90-d functional independence
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0088. Online ahead of print.ABSTRACTFischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104-15. 35810756.PMID:36315954 | DOI:10.7326/J22-0088
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Anthony A Donato Vaibhav Goswami Source Type: research
In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0090. Online ahead of print.ABSTRACTMenon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400:161-9. 35779553.PMID:36315948 | DOI:10.7326/J22-0090
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Emma Ferguson Eddy Lang Source Type: research
In acute ischemic stroke, thrombectomy was not noninferior to alteplase + thrombectomy for 90-d functional independence
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0088. Online ahead of print.ABSTRACTFischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104-15. 35810756.PMID:36315954 | DOI:10.7326/J22-0088
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Anthony A Donato Vaibhav Goswami Source Type: research
In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0090. Online ahead of print.ABSTRACTMenon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400:161-9. 35779553.PMID:36315948 | DOI:10.7326/J22-0090
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Emma Ferguson Eddy Lang Source Type: research
In acute ischemic stroke, thrombectomy was not noninferior to alteplase + thrombectomy for 90-d functional independence
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0088. Online ahead of print.ABSTRACTFischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104-15. 35810756.PMID:36315954 | DOI:10.7326/J22-0088
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Anthony A Donato Vaibhav Goswami Source Type: research
In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0090. Online ahead of print.ABSTRACTMenon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400:161-9. 35779553.PMID:36315948 | DOI:10.7326/J22-0090
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Emma Ferguson Eddy Lang Source Type: research
In basilar-artery occlusion stroke, thrombectomy improved functional outcomes without increasing ICH
Ann Intern Med. 2023 Feb 7. doi: 10.7326/J22-0120. Online ahead of print.ABSTRACTJovin TG, Li C, Wu L, et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med. 2022;387:1373-84. 36239645.PMID:36745898 | DOI:10.7326/J22-0120
Source: Annals of Internal Medicine - February 6, 2023 Category: Internal Medicine Authors: Bruce Lo Source Type: research
